Remora Biotech

Immunotherapy has an immense and growing impact on medicine and society : vaccines against pandemics, monoclonal antibodies the most successful class of drugs, breakthrough cures of cancer and autoimmune diseases, and new hopes to fight degenerative diseases. As immunologists and serial entrepreneurs, we contributed, at our small individual scale, to this biopharmaceutical revolution driven by immunology. We now join forces at Remora Biotech to leverage our entrepreneurial experience and, thanks to our supporting investors, to scale-up our ability to nurture and develop innovative life-changing immunotherapies. With our growing team and network of academic partners, business-oriented scientists, patent experts, drug developers...

Oncology,immunology,biotech,pharma,digital health,anti-aging,immunotherapy,botox,venture capital,cancer,and medtech

Remora biotech operates in the Venture capital and private equity principals industry.

Remora biotech's revenue is 11m - 100m

Remora biotech has 11 - 50 employees.